Skip to content

Drug interactions

Dapagliflozin + Insulin glargine-lixisenatide

Severity: Moderate

Dapagliflozin and Insulin glargine-lixisenatide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dapagliflozin lowers glucose independently of insulin, so together they increase the risk of hypoglycemia. Volume depletion and diabetic ketoacidosis are also concerns when insulin doses are reduced.

What this interaction means in plain words

Dapagliflozin and Insulin glargine-lixisenatide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dapagliflozin belongs to Endocrine; Insulin glargine-lixisenatide belongs to Endocrine.

Evidence level: High

Why it happens

Additive glucose lowering from SGLT2 inhibition-induced glucosuria plus insulin and GLP-1 receptor agonism.

What to do

Consider lowering the insulin dose when adding dapagliflozin and monitor glucose. Educate the patient on ketoacidosis symptoms and avoid abrupt large insulin reductions.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapagliflozin and Insulin glargine-lixisenatide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dapagliflozin with Insulin glargine-lixisenatide?

MediHelp rates the interaction as moderate. Dapagliflozin and Insulin glargine-lixisenatide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dapagliflozin lowers glucose independently of insulin, so together they increase the risk of hypoglycemia. Volume depletion and diabetic ketoacidosis are also concerns when insulin doses are reduced.

How serious is the interaction between Dapagliflozin and Insulin glargine-lixisenatide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider lowering the insulin dose when adding dapagliflozin and monitor glucose. Educate the patient on ketoacidosis symptoms and avoid abrupt large insulin reductions.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in